Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Murray H Passo

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Arthritis & Rheumatology (Hoboken, N.J.)|April 26, 2019
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and EnthesitisSarah Ringold, Sheila T Angeles-Han, Timothy Beukelman, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 30, 2017
High Levels of DEK Autoantibodies in Sera of Patients With Polyarticular Juvenile Idiopathic Arthritis and With Early Disease Flares Following Cessation of Anti-Tumor Necrosis Factor TherapyNirit Mor-Vaknin, Miguel Rivas, Maureen Legendre, et al.
Arthritis Care & Research|April 26, 2019
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and EnthesitisSarah Ringold, Sheila T Angeles-Han, Timothy Beukelman, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 26, 2019
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated UveitisSheila T Angeles-Han, Sarah Ringold, Timothy Beukelman, et al.
Arthritis Care & Research|April 26, 2019
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated UveitisSheila T Angeles-Han, Sarah Ringold, Timothy Beukelman, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 19, 2018
Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti-Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinuation of TherapyClaas H Hinze, Dirk Foell, Anne L Johnson, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 1, 2018
Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti-Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive DiseaseDaniel J Lovell, Anne L Johnson, Bin Huang, et al.
Nature Communications|March 18, 2023
Constitutively active Lyn kinase causes a cutaneous small vessel vasculitis and liver fibrosis syndromeAdriana A de Jesus, Guibin Chen, Dan Yang, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Arthritis & Rheumatology (Hoboken, N.J.)|April 26, 2019
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and EnthesitisSarah Ringold, Sheila T Angeles-Han, Timothy Beukelman, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 30, 2017
High Levels of DEK Autoantibodies in Sera of Patients With Polyarticular Juvenile Idiopathic Arthritis and With Early Disease Flares Following Cessation of Anti-Tumor Necrosis Factor TherapyNirit Mor-Vaknin, Miguel Rivas, Maureen Legendre, et al.
Arthritis Care & Research|April 26, 2019
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and EnthesitisSarah Ringold, Sheila T Angeles-Han, Timothy Beukelman, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 26, 2019
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated UveitisSheila T Angeles-Han, Sarah Ringold, Timothy Beukelman, et al.
Arthritis Care & Research|April 26, 2019
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated UveitisSheila T Angeles-Han, Sarah Ringold, Timothy Beukelman, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 19, 2018
Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti-Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinuation of TherapyClaas H Hinze, Dirk Foell, Anne L Johnson, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 1, 2018
Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti-Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive DiseaseDaniel J Lovell, Anne L Johnson, Bin Huang, et al.
Nature Communications|March 18, 2023
Constitutively active Lyn kinase causes a cutaneous small vessel vasculitis and liver fibrosis syndromeAdriana A de Jesus, Guibin Chen, Dan Yang, et al.
Pageof 4